Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Albemarle, a manufacturer of the anti-inflammatory agent ibuprofen and other active pharmaceutical ingredients, has signed a global agreement with Dr Reddy's Laboratories.
Subscribe to our email newsletter
As per the agreement, effective immediately, Albemarle has appointed Dr Reddy’s as a non-exclusive distributor of Albemarle’s bulk ibuprofen active pharmaceutical ingredient (API).
As part of the agreement, Dr Reddy’s will market, sell and distribute Albemarle’s ibuprofen API to Dr Reddy’s global client base. In addition, Albemarle will also supply Dr Reddy’s a substantial quantity of its ibuprofen API requirements for use in the company’s generic ibuprofen tablets.
Patrick Glaser, vice president for North America generics business at Dr Reddy’s, said: “Albemarle has been manufacturing ibuprofen for more than 25 years with a record of high quality, and the proven capacity to accommodate our significant volumes. We are confident that by working with Albemarle, we will be able to address our global ibuprofen requirements.”